Abstract

BackgroundCurrent outbreaks of COVID-19 are threatening the health care systems of several countries around the world. Control measures, based on isolation, contact tracing, and quarantine, can decrease and delay the burden of the ongoing epidemic. With respect to the ongoing COVID-19 epidemic, recent modeling work shows that these interventions may be inadequate to control local outbreaks, even when perfect isolation is assumed. The effect of infectiousness prior to symptom onset combined with asymptomatic infectees further complicates the use of contact tracing. We aim to study whether antivirals, which decrease the viral load and reduce infectiousness, could be integrated into control measures in order to augment the feasibility of controlling the epidemic.MethodsUsing a simulation-based model of viral transmission, we tested the efficacy of different intervention measures to control local COVID-19 outbreaks. For individuals that were identified through contact tracing, we evaluate two procedures: monitoring individuals for symptoms onset and testing of individuals. Additionally, we investigate the implementation of an antiviral compound combined with the contact tracing process.ResultsFor an infectious disease in which asymptomatic and presymptomatic infections are plausible, an intervention measure based on contact tracing performs better when combined with testing instead of monitoring, provided that the test is able to detect infections during the incubation period. Antiviral drugs, in combination with contact tracing, quarantine, and isolation, result in a significant decrease of the final size and the peak incidence, and increase the probability that the outbreak will fade out.ConclusionIn all tested scenarios, the model highlights the benefits of control measures based on the testing of traced individuals. In addition, the administration of an antiviral drug, together with quarantine, isolation, and contact tracing, is shown to decrease the spread of the epidemic. This control measure could be an effective strategy to control local and re-emerging outbreaks of COVID-19.

Highlights

  • Current outbreaks of COVID-19 are threatening the health care systems of several countries around the world

  • We investigate the use of contact tracing and isolation in combination with an antiviral compound to control local outbreaks of COVID-19, to avoid such invasive social measures, and to preemptively reduce the burden of the epidemic

  • We highlight the importance of testing compared to monitoring, and we show the impact of an antiviral compound that reduces the viral load and, the infectiousness of infectives

Read more

Summary

Introduction

Current outbreaks of COVID-19 are threatening the health care systems of several countries around the world. We chose to inform our model with data on the control of MERS-CoV viral load by remdesivir in a translational murine model [8]. This animal model was developed to better approximate the pharmacokinetics and drug exposure profile in humans. The measure of viral titers in lung tissue at different time points in this murine model serves as a reasonable proxy for viral dynamics upon compound exposure in the controlled setting of a viral challenge To this end, we calibrate the model to represent the viral load decrease thereof

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call